Outset Medical opened lower at $4.14, compared with its previous close of $4.17. In the last trading session, the stock traded between $3.91 and $4.21. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Outset Medical is now worth
$ 0.52
Resulting in a loss of
$ 99.48 (99.48%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 3 Analysts
Buy
66.67%
Hold
33.33%
Sell
0%
Markets Today
Today's Change
$-0.27 (-6.35%)
Day High
$4.21
Day Low
$3.91
Day Open
$4.14
Prev Close
$4.17
Volume
1,51,035
1W Return
-12.17%
1M Return
-3.01%
3M Return
-19.23%
6M Return
6.99%
1Y Return
-37.22%
Fundamentals
Market Cap ($ Mn)
74
PE Ratio
-
PB Ratio
0.77
PEG Ratio
-
ROE
-67.01%
ROCE
-30.59%
EPS (TTM)
$-0.78
Investment Returns
1 Week
-12.17%
1 Month
-3.01%
3 Months
-19.23%
6 Months
6.99%
9 Months
-13.99%
Financials
Quarterly
All values in $ Mn
31.4
Jun 25
29.4
Sep 25
28.9
Dec 25
27.9
Mar 26
31.6
Jun 26
33.6
Sep 26
Updates
5Nov
Outset Medical Q3FY26 Results: Revenue up 14% YoY to $33.6 million
Total revenue rose 14% YoY to $33.6 million, with console sales jumping 26%. Non-GAAP gross margin expanded 100 bps to 40.8%, driven by cost efficiencies. Operating expenses grew only 4% against 14% revenue growth, showing leverage. Full-year FY26 revenue guidance maintained at $125 million to $130 million.
8 days ago
22Oct
Outset Medical to report Q3 2026 results on November 4
Outset Medical will release Q3 2026 financial results on November 4, 2026. Conference call scheduled for 1:30 pm PT with CEO Leslie Trigg and CFO Renee Gaeta. Company highlights Tablo system usage across more than 1,000 US healthcare facilities.
22 days ago
7Aug
Outset Medical Q2 Results: Gross Margin Expands To 42%
Outset Medical’s Q2 2026 results show a 1% revenue increase to $31.6 million and a 42% gross margin, up from 37.8% YoY. A $40M HCA deal boosts backlog visibility. Net loss narrowed slightly to $18.0M, with strong service margin expansion offsetting product declines.
3mo ago
29Jul
Halper Sadeh probes Outset Medical insider fiduciary duties
Halper Sadeh LLC investigates Outset Medical, Inc. insiders for potential fiduciary duty breaches. Long-term shareholders are invited to join the effort to seek governance reforms and financial relief on a contingent fee basis.
3mo ago
3Jul
Outset Medical grants inducement awards to new hires
Outset Medical, Inc. approved equity awards for three new employees as an employment inducement under Nasdaq Listing Rule 5635(c)(4). The awards include restricted stock units (RSUs) and performance-based restricted stock units (PSUs) totaling 38,000 units. Derick Elliott, Executive Vice President of Commercial, received 24,000 PSUs.
